A detailed history of Capital World Investors transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Capital World Investors holds 7,828,372 shares of IONS stock, worth $277 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
7,828,372
Previous 2,252,089 247.6%
Holding current value
$277 Million
Previous $107 Million 192.18%
% of portfolio
0.05%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$40.06 - $51.86 $223 Million - $289 Million
5,576,283 Added 247.6%
7,828,372 $314 Million
Q2 2024

Aug 13, 2024

BUY
$36.45 - $47.7 $51.5 Million - $67.4 Million
1,412,626 Added 168.28%
2,252,089 $107 Million
Q2 2023

Aug 11, 2023

BUY
$34.73 - $43.33 $29.2 Million - $36.4 Million
839,463 New
839,463 $34.4 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.02B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Capital World Investors Portfolio

Follow Capital World Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.